Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Capitainer logo — Convenient and quantitative blood sampling at the fingertip...

Capitainer

Convenient and quantitative blood sampling at the fingertip for everyone, everywhere at anytime.

Founded 2016 Sweden Sweden 27 employees Series A Total: $154.07M Health Care

General Information

Company Name Capitainer
Founded Year 2016
Location Sweden Sweden +1
Employees 27
Industries Health Care
Funding Stage Series A
Social

Get notified when Capitainer moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Capitainer

Capitainer is a Sweden-based startup founded in 2016, specializing in revolutionizing blood sampling technology. Their slogan, "Convenient and quantitative blood sampling at the fingertip for everyone, everywhere at anytime," encapsulates their mission. The company has developed a cutting-edge microsystem technology, centered around a disposable sampling chip, enabling near-patient blood sampling, particularly suitable for at-home use. The proprietary sampling chip not only allows for the convenient collection of blood samples, but also meters and stores an exact blood volume, enabling quantitative measurements previously unattainable. This innovation is especially valuable for patients requiring continuous therapeutic drug monitoring. Through this, Capitainer aims to address a significant market need, with over a million therapeutic drug monitoring samples taken annually in Sweden alone. Notably, the company secured a kr15.00M Series A investment on 15th February 2024, with participation from We Venture Capital, Sciety Venture Partners, and Sciety. This investment underscores the confidence placed in Capitainer's innovative solution and its potential to revolutionize blood sampling practices, reduce healthcare resource expenditure, and improve patient experience. With its unique technological approach and clear market opportunity, Capitainer is poised to make a substantial impact in the healthcare industry.

Taxonomy: near patient sampling, Dry Blood Spot, Innovation, Self Sampling, Home Sampling, Microsampling, Healthcare Innovation, Therapeutic Drug Monitoring, Quantitative Blood Sampling, Healthcare Efficiency, Cost-saving, Environmental Impact, Remote Healthcare

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 3
Investor
•••• •••• 		15 Feb 2024
Series A •••••• 1 •••• •••• 24 Apr 2023
Venture Round •••••• 1 •••• •••• 29 Dec 2022
Series B •••••• 1 •••• •••• 31 May 2022
Series A •••••• 1 •••• •••• 18 Dec 2020

View All 7 Funding Rounds

Capitainer Alternatives & Competitors

Capitainer vs
Intuity Medical, Inc.
Intuity Medical, Inc. United States

Making life with diabetes easier

Debt Financing
65 employees
Biotechnology, Health Care
Compare Capitainer vs Intuity Medical, Inc.
Capitainer vs
DBS System
DBS System Switzerland

Making blood samples travel - not people.

Series A
6 employees
Health Care, Medical Devices
Compare Capitainer vs DBS System
Capitainer vs
ITL BioMedical
ITL BioMedical Australia

ITL offers medical devices and solutions to advance global health. Safety is at the forefront of eve...

64 employees
Biotechnology, Health Care
Compare Capitainer vs ITL BioMedical

FAQ About Capitainer

Convenient and quantitative blood sampling at the fingertip for everyone, everywhere at anytime.
Capitainer was founded in 2016.
Capitainer is headquartered in Sweden.
Capitainer operates in the following industries: Health Care.
Capitainer has approximately 27 employees.
Capitainer has completed 7 funding rounds, raising a total of $154.07M. The latest funding stage is Series A.
Top alternatives and competitors to Capitainer include Intuity Medical, Inc., DBS System, ITL BioMedical, Abreos Biosciences, Community Blood Center of Greater Kansas City. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Capitainer and Intuity Medical, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Capitainer and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes